Dr. Fleisher Discusses Monitoring Patients With ONJ
Dr. Ken Fleisher from New York University Discusses Monitoring Patients With ONJ
Dr. Fleisher Explains How Nurses Can Identify ONJ
Dr. Kenneth Fleisher from NYU College of Dentistry Explains How Nurses Can Identify osteonecrosis of the jaw.
Durvalumab Garners Similar OS, Albeit Varied PFS, Outcomes in EGFR+ and EGFR-Wildtype NSCLC Subgroups
Quizartinib Extends Overall Survival Across Multiple Subgroups in FLT3-ITD+ AML
Repotrectinib Showcases Early Intracranial Responses in Select ROS1+ NSCLC
Osimertinib May Be More Effective in Frontline EGFR+ NSCLC When Combined With Chemo
